ELIMINATION OF LIPOSOMAL AMPHOTERICIN BY HEMODIAFILTRATION

被引:8
作者
TOMLIN, M [1 ]
PRIESTLEY, GS [1 ]
机构
[1] SOUTHAMPTON GEN HOSP,DEPT ANAESTHET,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND
关键词
D O I
10.1007/BF01711556
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:699 / 700
页数:2
相关论文
共 5 条
[1]  
GOLPER TA, 1991, CONTRIB NEPHROL, V93, P110
[2]  
HUMPHREYS H, 1994, J ANTIMICROB CHEMOTH, V33, P1071
[3]   LIPOSOMAL AND LIPID FORMULATIONS OF AMPHOTERICIN-B - CLINICAL PHARMACOKINETICS [J].
JANKNEGT, R ;
DEMARIE, S ;
BAKKERWOUDENBERG, IAJM ;
CROMMELIN, DJA .
CLINICAL PHARMACOKINETICS, 1992, 23 (04) :279-291
[4]   LIPOSOMAL AMPHOTERICIN-B (AMBISOME) - SAFETY DATA FROM A PHASE-II/III CLINICAL-TRIAL [J].
MEUNIER, F ;
PRENTICE, HG ;
RINGDEN, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :83-91
[5]  
TOLLEMAR J, 1992, MYCOSES, V35, P215, DOI 10.1111/j.1439-0507.1992.tb00850.x